These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28219831)

  • 21. A new variant of Norovirus GII.4/2007 and inter-genotype recombinant strains of NVGII causing acute watery diarrhoea among children in Kolkata, India.
    Nayak MK; Chatterjee D; Nataraju SM; Pativada M; Mitra U; Chatterjee MK; Saha TK; Sarkar U; Krishnan T
    J Clin Virol; 2009 Jul; 45(3):223-9. PubMed ID: 19464942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The surface-exposed loop region of norovirus GII.3 VP1 plays an essential role in binding histo-blood group antigens.
    Zhang G; Wang J; Liu J; Zheng L; Wang W; Huo Y; Sun X
    Arch Virol; 2019 Jun; 164(6):1629-1638. PubMed ID: 30968211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of norovirus in Singapore, 2004-2011.
    Lim KL; Eden JS; Oon LL; White PA
    J Med Virol; 2013 Oct; 85(10):1842-51. PubMed ID: 23868077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic characterization of GII.3 noroviruses isolated from children in Zhengzhou city, China, 2015/16.
    Liu J; Li S; Wang C; Zheng L; Ma J; Li C; Huo Y; Wang Y
    Arch Virol; 2018 Oct; 163(10):2737-2742. PubMed ID: 29909464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
    Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
    Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant norovirus implicated in gastroenteritis outbreaks in Hiroshima Prefecture, Japan.
    Fukuda S; Sasaki Y; Takao S; Seno M
    J Med Virol; 2008 May; 80(5):921-8. PubMed ID: 18360906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of noroviruses associated with sporadic gastroenteritis in children in Novosibirsk, Russia, 2003-2012.
    Zhirakovskaia EV; Tikunov AY; Bodnev SA; Klemesheva VV; Netesov SV; Tikunova NV
    J Med Virol; 2015 May; 87(5):740-53. PubMed ID: 25693507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence and predominance of norovirus GII.17 in Huzhou, China, 2014-2015.
    Han J; Ji L; Shen Y; Wu X; Xu D; Chen L
    Virol J; 2015 Sep; 12():139. PubMed ID: 26362650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of genogroup II norovirus infection among hospitalized children with acute gastroenteritis in Suzhou (Jiangsu, China) from 2010 to 2013.
    Fu JG; Ai J; Zhang J; Wu QB; Qi X; Ji H; Jin M; Liu C; Wang SJ; Shan J; Bao CJ; Tang FY; Zhu YF
    J Med Virol; 2016 Jun; 88(6):954-60. PubMed ID: 26547266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
    Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
    J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of noroviruses detected in Nepalese children with acute diarrhea between 2005 and 2011: increase and predominance of minor genotype GII.13.
    Hoa-Tran TN; Nakagomi T; Sano D; Sherchand JB; Pandey BD; Cunliffe NA; Nakagomi O
    Infect Genet Evol; 2015 Mar; 30():27-36. PubMed ID: 25497351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia.
    Ayouni S; Estienney M; Sdiri-Loulizi K; Ambert-Balay K; de Rougemont A; Aho S; Hammami S; Aouni M; Guédiche MN; Pothier P; Belliot G
    Clin Microbiol Infect; 2015 Sep; 21(9):874.e1-8. PubMed ID: 26003283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated norovirus GII.7 strain within an extended GII.4 outbreak.
    Hoffmann D; Seebach J; Foley BT; Frösner G; Nadas K; Protzer U; Schätzl HM
    J Med Virol; 2010 May; 82(6):1058-64. PubMed ID: 20419822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
    Chen W; Kang T; Yuan R; Shao C; Jing S
    Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of chimeric proteins based on a backbone of the GII.4 norovirus VP1 and their application in the study of a GII.6 norovirus-specific blockade epitope.
    Huo Y; Ma J; Zheng L; Liu J; Yang Z; Wang C; Zhao Q
    Arch Virol; 2022 Mar; 167(3):819-827. PubMed ID: 35112202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.